Health Behaviors in Patients Who Have Finished Treatment for Stage I, Stage II, or Stage III Colorectal Cancer

Sponsor
Rutgers, The State University of New Jersey (Other)
Overall Status
Completed
CT.gov ID
NCT00966667
Collaborator
National Cancer Institute (NCI) (NIH), Rutgers Cancer Institute of New Jersey (Other)
222
14
117.2
15.9
0.1

Study Details

Study Description

Brief Summary

RATIONALE: Gathering information over time from patients who have finished treatment for colorectal cancer may help doctors predict which cancer survivors will improve their physical activity and diet.

PURPOSE: This clinical trial is studying health behaviors in patients who have finished treatment for stage I, stage II, or stage III colorectal cancer.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    OBJECTIVES:

    Primary

    • To characterize patterns and identify predictors of post-treatment physical activity and dietary changes made by colorectal cancer survivors.

    Secondary

    • To identify the affective and cognitive effects of post-treatment physical activity and dietary changes in these patients.

    • To identify these patients' preferences regarding diet and physical activity health promotion programs.

    OUTLINE: This is a multicenter study.

    Patients complete surveys at baseline and at 3 and 6 months. A randomly selected subset of 84 patients also receive an activity monitor to be use at each of the 3 time points. The acceptability of their use is assessed and whether activity levels change across the 3 time points and the extent to which they are convergent with self-reported physical activity are examined.

    During each survey, questionnaires are administered to assess the following areas:

    physical/medical characteristics (self-reported), self-efficacy for physical activity, fruit and vegetable consumption, and dietary fat intake; outcome expectations for physical activity, fruit and vegetable consumption, and dietary fat intake; physical activity and diet behavioral self-regulation; illness representations (causal attributions and controllability of recurrence); perceived risk of colorectal cancer (CRC) recurrence; emotional representations of CRC (cancer-related anxiety and worry about cancer recurrence); healthcare provider recommendations to alter physical activity and dietary intake; social influence from important others; current physical activity and dietary intake; and diet and physical activity program preferences. Patients who received the activity monitor are asked feedback on acceptability of them.

    Measures of sociodemographics and disease/treatment characteristics (via medical chart review) are recorded.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    222 participants
    Observational Model:
    Ecologic or Community
    Time Perspective:
    Prospective
    Official Title:
    Health Behaviors Among Individuals Diagnosed With Colorectal Cancer
    Study Start Date :
    Nov 1, 2009
    Actual Primary Completion Date :
    Aug 7, 2019
    Actual Study Completion Date :
    Aug 7, 2019

    Arms and Interventions

    Arm Intervention/Treatment
    cancer survivor

    cancer survivor

    Outcome Measures

    Primary Outcome Measures

    1. Self-efficacy for changing physical activity and dietary practices [3 yrs]

    2. Outcome expectations with regard to physical activity and dietary practices [3 yrs]

    3. Behavioral self-regulation of physical activity and dietary practices [3 yrs]

    4. Perceived role of physical activity and dietary factors in causing colorectal cancer (CRC) and preventing recurrence (CRC illness representations) [3 yrs]

    5. Perceived risk of CRC recurrence [3 yrs]

    6. Cancer-related anxiety and worry about cancer recurrence (emotional representations of CRC) [3 yrs]

    7. Receipt of healthcare provider recommendations to alter physical activity and diet [3 yrs]

    8. Normative influences of family and friends [3 yrs]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    21 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    DISEASE CHARACTERISTICS:
    • Diagnosis of localized or regional colorectal cancer

    • Stage I, II, or III disease

    • Completed treatment within the past 6 weeks

    • No previous diagnosis of colorectal cancer

    PATIENT CHARACTERISTICS:
    • English speaking

    • No current evidence of neoplastic disease except for nonmelanoma skin cancer

    • No evidence of severe cognitive impairment

    PRIOR CONCURRENT THERAPY:
    • See Disease Characteristics

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Cooper Hospital/University Medical Center Camden New Jersey United States 08103
    2 JFK Medical Center in Edison Edison New Jersey United States 08818
    3 Centrastate Healthcare System Freehold New Jersey United States 07728
    4 Robert Wood Johnson University Hospital at Hamilton Hamilton New Jersey United States 08690
    5 Mountainside Hospital Montclair New Jersey United States 07042
    6 Morristown Medical Center Morristown New Jersey United States 07962
    7 Jersey Shore University Medical Center Neptune New Jersey United States 07754
    8 Rutgers Cancer Institute of New Jersey New Brunswick New Jersey United States 08903
    9 Saint Peters University Hospital New Brunswick New Jersey United States 08903
    10 University Medical Center at Princeton Princeton New Jersey United States 08540
    11 Robert Wood Johnson University Hospital Somerset Somerville New Jersey United States
    12 Overlook Medical Center Summit New Jersey United States 07901
    13 Fox Chase Cancer Center Philadelphia Pennsylvania United States
    14 MD Anderson Cancer Center Houston Texas United States 77030

    Sponsors and Collaborators

    • Rutgers, The State University of New Jersey
    • National Cancer Institute (NCI)
    • Rutgers Cancer Institute of New Jersey

    Investigators

    • Principal Investigator: Elliot Coups, PhD, Rutgers Cancer Institute of New Jersey

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Rutgers, The State University of New Jersey
    ClinicalTrials.gov Identifier:
    NCT00966667
    Other Study ID Numbers:
    • 130901
    • R21CA131611
    • P30CA072720
    • K07CA133100
    • CDR0000653167
    • 0220090178
    First Posted:
    Aug 27, 2009
    Last Update Posted:
    Sep 10, 2019
    Last Verified:
    Sep 1, 2019

    Study Results

    No Results Posted as of Sep 10, 2019